52 related articles for article (PubMed ID: 6574818)
1. Characteristics of a calcitonin-responsive cell line derived from a human osteosarcoma.
Eilon G; Perkins J; Viola MV
Cancer Res; 1983 Aug; 43(8):3763-9. PubMed ID: 6574818
[TBL] [Abstract][Full Text] [Related]
2. New bone resorption stimulation factor elaborated by a human osteosarcoma cell line.
Eilon G; Trummel C; Kream B; Viola MV
Cancer Res; 1984 Jan; 44(1):209-14. PubMed ID: 6606487
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of cell lines derived from a human osteosarcoma.
Yamane T
Clin Orthop Relat Res; 1985 Oct; (199):261-71. PubMed ID: 3862491
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the human mandibular osteoblastic osteosarcoma cell line HOSM-2 after long-term culture.
Narita M; Nomura J; Nakase M; Inui M; Murata T; Hamaguchi Y; Tagawa T
Oral Oncol; 2004 Aug; 40(7):742-50. PubMed ID: 15172645
[TBL] [Abstract][Full Text] [Related]
5. Specific receptors for epidermal growth factor in human bone tumour cells and its effect on synthesis of prostaglandin E2 by cultured osteosarcoma cell line.
Hirata Y; Uchihashi M; Nakashima H; Fujita T; Matsukura S; Matsui K
Acta Endocrinol (Copenh); 1984 Sep; 107(1):125-30. PubMed ID: 6091385
[TBL] [Abstract][Full Text] [Related]
6. Osteogenic potential of murine osteosarcoma cells: comparison of bone-specific gene expression in in vitro and in vivo conditions.
Gerstenfeld LC; Uporova T; Schmidt J; Strauss PG; Shih SD; Huang LF; Gundberg C; Mizuno S; Glowacki J
Lab Invest; 1996 May; 74(5):895-906. PubMed ID: 8642785
[TBL] [Abstract][Full Text] [Related]
7. Human amniotic tumor that induces new bone formation in vivo produces growth-regulatory activity in vitro for osteoblasts identified as an extended form of basic fibroblast growth factor.
Izbicka E; Dunstan C; Esparza J; Jacobs C; Sabatini M; Mundy GR
Cancer Res; 1996 Feb; 56(3):633-6. PubMed ID: 8564983
[TBL] [Abstract][Full Text] [Related]
8. Bone biology and physiology: implications for novel osteoblastic osteosarcoma treatments?
Spangler JG
Med Hypotheses; 2008; 70(2):281-6. PubMed ID: 17683874
[TBL] [Abstract][Full Text] [Related]
9. Binding and activation of plasminogen on the surface of osteosarcoma cells.
Campbell PG; Wines K; Yanosick TB; Novak JF
J Cell Physiol; 1994 Apr; 159(1):1-10. PubMed ID: 7511144
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
Kuestner RE; Elrod RD; Grant FJ; Hagen FS; Kuijper JL; Matthewes SL; O'Hara PJ; Sheppard PO; Stroop SD; Thompson DL
Mol Pharmacol; 1994 Aug; 46(2):246-55. PubMed ID: 8078488
[TBL] [Abstract][Full Text] [Related]
11. Role of tumor necrosis factor alpha in particulate-induced bone resorption.
Algan SM; Purdon M; Horowitz SM
J Orthop Res; 1996 Jan; 14(1):30-5. PubMed ID: 8618163
[TBL] [Abstract][Full Text] [Related]
12. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
Shoieb AM; Hahn KA; Barnhill MA
In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2.
Postiglione L; Domenico GD; Montagnani S; Spigna GD; Salzano S; Castaldo C; Ramaglia L; Sbordone L; Rossi G
Calcif Tissue Int; 2003 Jan; 72(1):85-97. PubMed ID: 12232677
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
15. FK506 enhanced osteoblastic differentiation in mesenchymal cells.
Tang L; Ebara S; Kawasaki S; Wakabayashi S; Nikaido T; Takaoka K
Cell Biol Int; 2002; 26(1):75-84. PubMed ID: 11779223
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
Robinson RA; Branum EL; Volkenant ME; Moses HL
Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
Weber KL; Pathak S; Multani AS; Price JE
J Urol; 2002 Aug; 168(2):774-9. PubMed ID: 12131367
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases.
Zou CY; Wang J; Shen JN; Huang G; Jin S; Yin JQ; Guo QC; Li HM; Luo L; Zhang M; Zhang LJ
Acta Pharmacol Sin; 2008 Mar; 29(3):325-32. PubMed ID: 18298897
[TBL] [Abstract][Full Text] [Related]
19. Human pulp cells respond to calcitonin gene-related peptide in vitro.
Calland JW; Harris SE; Carnes DL
J Endod; 1997 Aug; 23(8):485-9. PubMed ID: 9587316
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
Mackie PS; Fisher JL; Zhou H; Choong PF
Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
